![Julie Feder](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Julie Feder
Inga fler pågående positioner
Profil
Julie B. Feder is currently Chief Financial Officer at Obsidian Therapeutics, Inc. Formerly, Ms. Feder was Chief Financial Officer at Aura Biosciences, Inc. from 2018 to 2024, Chief Financial Officer at Verastem, Inc. from 2017 to 2018, Chief Financial Officer at Clinton Health Access Initiative from 2011 to 2017, Vice President-Internal Audit at Genzyme Corp.
from 2008 to 2011, and Senior Manager-Audit, Consulting & Enterprise Risk at Deloitte & Touche LLP from 1991 to 2008.
Ms. Feder completed undergraduate studies at Sy Syms School of Business.
Aktiva positioner av Julie Feder
| Företag | Position | Start |
|---|
Tidigare kända positioner av Julie Feder
| Företag | Position | Slut |
|---|---|---|
| AURA BIOSCIENCES, INC. | Finansdirektör/CFO | 2024-10-25 |
| VERASTEM, INC. | Finansdirektör/CFO | 2018-06-01 |
Clinton Health Access Initiative
 Clinton Health Access Initiative Miscellaneous Commercial ServicesCommercial Services Engages in saving lives and reducing diseases through through antiretroviral treatment | Finansdirektör/CFO | 2017-07-01 |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Företagsledare/Principal | 2008-01-01 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Comptroller/Controller/Revisor | - |
Julie Feders utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
96
Första gradens relationer
6
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Aura Biosciences, Inc.
 Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Commercial Services |
Verastem, Inc.
 Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
Clinton Health Access Initiative
Clinton Health Access Initiative Miscellaneous Commercial ServicesCommercial Services Engages in saving lives and reducing diseases through through antiretroviral treatment | Commercial Services |
Sy Syms School of Business
 Sy Syms School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
